D.E. Shaw & Co’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$95.3K Sell
11,873
-14,654
-55% -$140K ﹤0.01% 4289
2025
Q4
$309K Sell
26,527
-7,692
-22% -$74.8K ﹤0.01% 4132
2025
Q3
$344K Sell
34,219
-23,230
-40% -$333K ﹤0.01% 4042
2025
Q2
$1M Buy
57,449
+23,652
+70% +$341K ﹤0.01% 3236
2025
Q1
$425K Sell
33,797
-42,935
-56% -$517K ﹤0.01% 3584
2024
Q4
$810K Sell
76,732
-3,816
-5% -$53.4K ﹤0.01% 3330
2024
Q3
$1.17M Buy
80,548
+12,315
+18% +$146K ﹤0.01% 3162
2024
Q2
$581K Buy
68,233
+30,056
+79% +$267K ﹤0.01% 3532
2024
Q1
$390K Buy
+38,177
New +$285K ﹤0.01% 3602
2023
Q2
Sell
-24,302
Closed -$158K 4532
2023
Q1
$158K Sell
24,302
-19,396
-44% -$149K ﹤0.01% 3943
2022
Q4
$373K Buy
43,698
+14,409
+49% +$93.5K ﹤0.01% 3995
2022
Q3
$155K Sell
29,289
-62,834
-68% -$310K ﹤0.01% 4537
2022
Q2
$391K Sell
92,123
-95,199
-51% -$332K ﹤0.01% 4236
2022
Q1
$658K Sell
187,322
-62,694
-25% -$273K ﹤0.01% 4204
2021
Q4
$1.67M Sell
250,016
-564
-0.2% -$4.58K ﹤0.01% 3521
2021
Q3
$2.5M Buy
250,580
+40,453
+19% +$998K ﹤0.01% 2826
2021
Q2
$6.49M Buy
210,127
+4,714
+2% +$151K 0.01% 1835
2021
Q1
$8.96M Buy
+205,413
New +$9.72M 0.01% 1435

Other funds holding SPRY